Dedifferentiated parosteal osteosarcoma of the maxilla

A case report and review of the literature

Hidetaka Miyashita, Kazunari Yoshida, Tomoya Soma, Kaori Kameyama, Aya Sasaki, Masanori Hisaoka, Masaki Yazawa, Hideo Morioka, Moe Takahashi, Taneaki Nakagawa, Hiromasa Kawana

Research output: Contribution to journalArticle

Abstract

Background: Parosteal osteosarcomas are usually low-grade tumors, however, sometimes they transform to high-grade tumors, which is named dedifferentiation. This phenomenon has been reported in long bones. Recently, we encountered a patient with dedifferentiated parosteal osteosarcoma occurring in the maxilla. Here, we report a first case of dedifferentiated parosteal osteosarcoma of the head and neck region. Case presentation: A 45-year-old Japanese woman with a refractory bone lesion in the maxilla presented to our hospital. A biopsy showed atypical spindle cell proliferation involving dedifferentiated high-grade component, which was diagnosed as dedifferentiated parosteal osteosarcoma. Three cycles of neoadjuvant chemotherapy using ifosfamide and pirarubicin were performed followed by sub-total maxillectomy. Histopathological results showed that neoadjuvant chemotherapy was effective for high-grade component. The decision to perform adjuvant chemotherapy (cisplatin and pirarubicin) was made because distant metastasis has been reported, even in cases with dedifferentiated parosteal osteosarcoma in which complete necrosis of high-grade component was achieved due to neoadjuvant chemotherapy. There was no recurrence 15 months after surgery. Conclusions: Dedifferentiated parosteal osteosarcoma can occur in the head and neck region. Chemotherapy including anthracycline anticancer agent could be effective for high-grade component of dedifferentiated parosteal osteosarcoma.

Original languageEnglish
Article number235
JournalJournal of Medical Case Reports
Volume12
Issue number1
DOIs
Publication statusPublished - 2018 Aug 17

Fingerprint

Maxilla
Osteosarcoma
Drug Therapy
Neck
Head
Bone and Bones
Ifosfamide
Anthracyclines
Adjuvant Chemotherapy
Antineoplastic Agents
Cisplatin
Neoplasms
Necrosis
Cell Proliferation
Neoplasm Metastasis
Biopsy
Recurrence

Keywords

  • Case report
  • Chemotherapy
  • Dedifferentiated
  • Head and neck
  • Maxilla
  • Parosteal osteosarcoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dedifferentiated parosteal osteosarcoma of the maxilla : A case report and review of the literature. / Miyashita, Hidetaka; Yoshida, Kazunari; Soma, Tomoya; Kameyama, Kaori; Sasaki, Aya; Hisaoka, Masanori; Yazawa, Masaki; Morioka, Hideo; Takahashi, Moe; Nakagawa, Taneaki; Kawana, Hiromasa.

In: Journal of Medical Case Reports, Vol. 12, No. 1, 235, 17.08.2018.

Research output: Contribution to journalArticle

@article{3eb6bf8bb91b49e6a74659be6564a30d,
title = "Dedifferentiated parosteal osteosarcoma of the maxilla: A case report and review of the literature",
abstract = "Background: Parosteal osteosarcomas are usually low-grade tumors, however, sometimes they transform to high-grade tumors, which is named dedifferentiation. This phenomenon has been reported in long bones. Recently, we encountered a patient with dedifferentiated parosteal osteosarcoma occurring in the maxilla. Here, we report a first case of dedifferentiated parosteal osteosarcoma of the head and neck region. Case presentation: A 45-year-old Japanese woman with a refractory bone lesion in the maxilla presented to our hospital. A biopsy showed atypical spindle cell proliferation involving dedifferentiated high-grade component, which was diagnosed as dedifferentiated parosteal osteosarcoma. Three cycles of neoadjuvant chemotherapy using ifosfamide and pirarubicin were performed followed by sub-total maxillectomy. Histopathological results showed that neoadjuvant chemotherapy was effective for high-grade component. The decision to perform adjuvant chemotherapy (cisplatin and pirarubicin) was made because distant metastasis has been reported, even in cases with dedifferentiated parosteal osteosarcoma in which complete necrosis of high-grade component was achieved due to neoadjuvant chemotherapy. There was no recurrence 15 months after surgery. Conclusions: Dedifferentiated parosteal osteosarcoma can occur in the head and neck region. Chemotherapy including anthracycline anticancer agent could be effective for high-grade component of dedifferentiated parosteal osteosarcoma.",
keywords = "Case report, Chemotherapy, Dedifferentiated, Head and neck, Maxilla, Parosteal osteosarcoma",
author = "Hidetaka Miyashita and Kazunari Yoshida and Tomoya Soma and Kaori Kameyama and Aya Sasaki and Masanori Hisaoka and Masaki Yazawa and Hideo Morioka and Moe Takahashi and Taneaki Nakagawa and Hiromasa Kawana",
year = "2018",
month = "8",
day = "17",
doi = "10.1186/s13256-018-1747-3",
language = "English",
volume = "12",
journal = "Journal of Medical Case Reports",
issn = "1752-1947",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Dedifferentiated parosteal osteosarcoma of the maxilla

T2 - A case report and review of the literature

AU - Miyashita, Hidetaka

AU - Yoshida, Kazunari

AU - Soma, Tomoya

AU - Kameyama, Kaori

AU - Sasaki, Aya

AU - Hisaoka, Masanori

AU - Yazawa, Masaki

AU - Morioka, Hideo

AU - Takahashi, Moe

AU - Nakagawa, Taneaki

AU - Kawana, Hiromasa

PY - 2018/8/17

Y1 - 2018/8/17

N2 - Background: Parosteal osteosarcomas are usually low-grade tumors, however, sometimes they transform to high-grade tumors, which is named dedifferentiation. This phenomenon has been reported in long bones. Recently, we encountered a patient with dedifferentiated parosteal osteosarcoma occurring in the maxilla. Here, we report a first case of dedifferentiated parosteal osteosarcoma of the head and neck region. Case presentation: A 45-year-old Japanese woman with a refractory bone lesion in the maxilla presented to our hospital. A biopsy showed atypical spindle cell proliferation involving dedifferentiated high-grade component, which was diagnosed as dedifferentiated parosteal osteosarcoma. Three cycles of neoadjuvant chemotherapy using ifosfamide and pirarubicin were performed followed by sub-total maxillectomy. Histopathological results showed that neoadjuvant chemotherapy was effective for high-grade component. The decision to perform adjuvant chemotherapy (cisplatin and pirarubicin) was made because distant metastasis has been reported, even in cases with dedifferentiated parosteal osteosarcoma in which complete necrosis of high-grade component was achieved due to neoadjuvant chemotherapy. There was no recurrence 15 months after surgery. Conclusions: Dedifferentiated parosteal osteosarcoma can occur in the head and neck region. Chemotherapy including anthracycline anticancer agent could be effective for high-grade component of dedifferentiated parosteal osteosarcoma.

AB - Background: Parosteal osteosarcomas are usually low-grade tumors, however, sometimes they transform to high-grade tumors, which is named dedifferentiation. This phenomenon has been reported in long bones. Recently, we encountered a patient with dedifferentiated parosteal osteosarcoma occurring in the maxilla. Here, we report a first case of dedifferentiated parosteal osteosarcoma of the head and neck region. Case presentation: A 45-year-old Japanese woman with a refractory bone lesion in the maxilla presented to our hospital. A biopsy showed atypical spindle cell proliferation involving dedifferentiated high-grade component, which was diagnosed as dedifferentiated parosteal osteosarcoma. Three cycles of neoadjuvant chemotherapy using ifosfamide and pirarubicin were performed followed by sub-total maxillectomy. Histopathological results showed that neoadjuvant chemotherapy was effective for high-grade component. The decision to perform adjuvant chemotherapy (cisplatin and pirarubicin) was made because distant metastasis has been reported, even in cases with dedifferentiated parosteal osteosarcoma in which complete necrosis of high-grade component was achieved due to neoadjuvant chemotherapy. There was no recurrence 15 months after surgery. Conclusions: Dedifferentiated parosteal osteosarcoma can occur in the head and neck region. Chemotherapy including anthracycline anticancer agent could be effective for high-grade component of dedifferentiated parosteal osteosarcoma.

KW - Case report

KW - Chemotherapy

KW - Dedifferentiated

KW - Head and neck

KW - Maxilla

KW - Parosteal osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=85051709707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051709707&partnerID=8YFLogxK

U2 - 10.1186/s13256-018-1747-3

DO - 10.1186/s13256-018-1747-3

M3 - Article

VL - 12

JO - Journal of Medical Case Reports

JF - Journal of Medical Case Reports

SN - 1752-1947

IS - 1

M1 - 235

ER -